Medication Development in Alcoholism: Acamprosate Versus Naltrexone
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to develop and validate a human laboratory model for prediction
of medication efficacy in clinical trials for relapse prevention in alcohol dependence.
Phase:
Phase 2
Details
Lead Sponsor:
The Scripps Research Institute
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)